Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|April 1, 2015
Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST TrialAdam J Mead, Dragana Milojkovic, Steven Knapper, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Machine learning identifies novel signatures of antifungal drug resistance in Saccharomycotina yeastsMarie-Claire Harrison, David C Rinker, Abigail L LaBella, et al.
European Journal of Haematology|October 14, 2024
Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of SurvivalHelen Ajufo, Jan Philipp Bewersdorf, Claire Harrison, et al.
G3 (Bethesda, Md.)|August 12, 2025
Genomic factors limiting the diversity of Saccharomycotina plant pathogensSun Lee, Caroline West, Dana A Opulente, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Genomic factors limiting the diversity of Saccharomycotina plant pathogensSun Lee, Caroline West, Dana A Opulente, et al.
British Journal of Haematology|July 31, 2021
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosisAnimesh Pardanani, Ayalew Tefferi, Tamás Masszi, et al.
Plos Biology|September 23, 2024
Diverse signatures of convergent evolution in cactus-associated yeastsCarla Gonçalves, Marie-Claire Harrison, Jacob L Steenwyk, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Diverse signatures of convergent evolution in cacti-associated yeastsCarla Gonçalves, Marie-Claire Harrison, Jacob L Steenwyk, et al.
Pageof 17